39 companies, largest first.

About Medical Device Stocks

Devices are the quality end of healthcare and get priced like it. The multiples are high, the growth is steady, and the reason is the razor and blades arrangement underneath: the equipment goes into a hospital once, then sells single-use kits, catheters and implants every time a procedure happens.

Once a surgeon is trained on a system, switching is genuinely painful, which produces the kind of pricing power the rest of healthcare does not have. It also means the installed base matters more than new equipment orders, and a company selling lots of hardware at thin margins can be building a better annuity than its earnings currently show.

The demand driver is procedure volume, so this group is exposed to hospital staffing, hospital capital budgets, and whether an insurer reimburses a given procedure at all. Reimbursement decisions are the underappreciated risk: a payer declining to cover something can end a product line without any competitor doing anything. Weight-loss drugs suppressing demand for some surgeries is a live version of the same problem.

Keep going

Track Medical Device Stocks with alerts

Get notified when any of these hit your price targets or technical conditions.

Get Started Free